v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
OPERATING ACTIVITIES:              
Net income $ 9,746,000 $ (1,171,000) $ (1,000,000) $ 2,373,000 $ 8,575,000 $ 1,373,000  
Adjustments to reconcile consolidated net income to net cash provided by operating activities:              
Depreciation and amortization         10,321,000 12,009,000  
Deferred financing cost amortization         1,096,000 1,477,000  
Changes in fair value of derivative liabilities (7,566,000)   6,427,000   (4,196,000) 8,737,000  
Exercise of warrants         200,000 0  
Loss on conversion of Convertible Notes 0   902,000   0 902,000  
Above (below) market lease amortization, net (360,000)   (685,000)   (720,000) (1,425,000)  
Paid-in-kind interest         1,786,000 2,006,000  
Gain on preferred stock redemptions (111,000)   (228,000)   (290,000) (1,046,000)  
Straight-line income         (44,000) (37,000)  
Gain on disposal of properties, net         (7,442,000) (10,877,000)  
Credit adjustments on operating lease receivables 207,000   154,000   520,000 586,000  
Impairment charges 1,590,000   0   1,590,000 0  
Net changes in assets and liabilities:              
Receivables, net         863,000 (1,716,000)  
Deferred costs and other assets, net         (743,000) (975,000)  
Accounts payable, accrued expenses and other liabilities         949,000 2,310,000  
Net cash provided by operating activities         12,465,000 13,324,000  
INVESTING ACTIVITIES:              
Expenditures for real estate improvements         (4,270,000) (8,069,000)  
Purchases of investment securities - related party         (5,000,000) 0  
Cash received from disposal of properties         21,642,000 33,412,000  
Net cash provided by investing activities         12,372,000 25,343,000  
FINANCING ACTIVITIES:              
Proceeds from exercise of warrants         2,000 0  
Payments for deferred financing costs         0 (193,000)  
Dividends and distributions paid on noncontrolling interest         (2,414,000) (3,674,000)  
Repurchase of noncontrolling interest         0 (31,784,000)  
Loan proceeds         0 10,000,000  
Loan principal payments         (11,144,000) (15,082,000)  
Loan prepayment premium         (123,000) (573,000)  
Net cash used in financing activities         (13,679,000) (41,306,000)  
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH         11,158,000 (2,639,000)  
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period   $ 48,629,000   $ 60,716,000 48,629,000 60,716,000 $ 60,716,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period 59,787,000   58,077,000   59,787,000 58,077,000 48,629,000
Supplemental Disclosure:              
Cash and cash equivalents 31,873,000   28,065,000   31,873,000 28,065,000 23,656,000
Restricted cash 27,914,000   30,012,000   27,914,000 30,012,000 24,973,000
Cash, cash equivalents, and restricted cash $ 59,787,000   $ 58,077,000   $ 59,787,000 $ 58,077,000 $ 48,629,000